AAAAAA
Results:
1-12
|
Results: 12
Authors:
RIORDAN M
WEIDEN PL
Citation: M. Riordan et Pl. Weiden, FACTOR-V-LEIDEN MUTATION DOES NOT ACCOUNT FOR CENTRAL VENOUS CATHETER-RELATED THROMBOSIS, American journal of hematology, 58(2), 1998, pp. 150-152
Authors:
WEIDEN PL
BAUERMEISTER DE
FATTA EA
Citation: Pl. Weiden et al., AN ASIAN MAN WITH ENLARGED GLANDS, Lancet, 351(9109), 1998, pp. 1098-1098
Authors:
BREITZ HB
TYLER A
BJORN MJ
LESLEY T
WEIDEN PL
Citation: Hb. Breitz et al., CLINICAL-EXPERIENCE WITH TC-99M NOFETUMOMAB MERPENTAN (VERLUMA) RADIOIMMUNOSCINTIGRAPHY, Clinical nuclear medicine, 22(9), 1997, pp. 615-620
Authors:
THOMAS CR
WEIDEN PL
TRAVERSO LW
THOMPSON T
Citation: Cr. Thomas et al., CONCOMITANT INTRAARTERIAL CISPLATIN, INTRAVENOUS 5-FLUOROURACIL, AND SPLIT-COURSE RADIATION-THERAPY FOR LOCALLY ADVANCED UNRESECTABLE PANCREATIC ADENOCARCINOMA - A PHASE-II STUDY OF THE PUGET-SOUND-ONCOLOGY-CONSORTIUM (PSOC-703), American journal of clinical oncology, 20(2), 1997, pp. 161-165
Authors:
BRUNVAND MW
BENSINGER WI
SOLL E
WEAVER CH
ROWLEY SD
APPELBAUM FR
LILLEBY K
CLIFT RA
GOOLEY TA
PRESS OW
FEFER A
STORB R
SANDERS JE
MARTIN PL
CHAUNCEY T
MAZIARZ RT
ZUCKERMAN N
MONTGOMERY P
DORN R
WEIDEN PL
DEMIRER T
HOLMBERG LA
SCHIFFMAN K
MCSWEENEY PA
MALONEY DG
BUCKNER CD
Citation: Mw. Brunvand et al., HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR TREATMENT OF MALIGNANT-LYMPHOMA - COMPARISON OF AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS, Bone marrow transplantation, 18(1), 1996, pp. 131-141
Authors:
WEIDEN PL
APPELBAUM JW
Citation: Pl. Weiden et Jw. Appelbaum, PERCEPTIONS OF CANCER-PATIENTS AND THEIR PHYSICIANS INVOLVED IN PHASE-I CLINICAL-TRIALS, Journal of clinical oncology, 13(9), 1995, pp. 2472-2472
Authors:
BREITZ HB
DURHAM JS
FISHER DR
WEIDEN PL
DENARDO GL
GOODGOLD HM
NELP WB
Citation: Hb. Breitz et al., PHARMACOKINETICS AND NORMAL ORGAN DOSIMETRY FOLLOWING INTRAPERITONEALRHENIUM-186-LABELED MONOCLONAL-ANTIBODY, The Journal of nuclear medicine, 36(5), 1995, pp. 754-761
Authors:
BREITZ HB
DURHAM JS
FISHER DR
WEIDEN PL
Citation: Hb. Breitz et al., RADIATION-ABSORBED DOSE ESTIMATES TO NORMAL ORGANS FOLLOWING INTRAPERITONEAL RE-186-LABELED MONOCLONAL-ANTIBODY - METHODS AND RESULTS, Cancer research, 55(23), 1995, pp. 5817-5822
Authors:
WEIDEN PL
PIANTADOSI S
Citation: Pl. Weiden et S. Piantadosi, PREOPERATIVE CHEMOTHERAPY (CISPLATIN AND FLUOROURACIL) AND RADIATION-THERAPY IN STAGE-III NONSMALL CELL LUNG-CANCER - A PHASE-2 STUDY OF THE LCSG, Chest, 106(6), 1994, pp. 190000344-190000347
Authors:
WEIDEN PL
WOLF SB
BREITZ HB
APPELBAUM JW
SEILER CA
MALLETT R
BJORN MJ
SU FM
FER NF
SALK D
Citation: Pl. Weiden et al., HUMAN ANTI-MOUSE ANTIBODY SUPPRESSION WITH CYCLOSPORINE-A, Cancer, 73(3), 1994, pp. 1093-1097
Authors:
BREITZ HB
FISHER DR
WEIDEN PL
DURHAM JS
RATLIFF BA
BJORN MJ
BEAUMIER PL
ABRAMS PG
Citation: Hb. Breitz et al., DOSIMETRY OF RHENIUM-186-LABELED MONOCLONAL-ANTIBODIES - METHODS, PREDICTION FROM TC-99M-LABELED ANTIBODIES AND RESULTS OF PHASE-I TRIALS, The Journal of nuclear medicine, 34(6), 1993, pp. 908-917
Authors:
WEIDEN PL
BREITZ HB
SEILER CA
BJORN MJ
RATLIFF BA
MALLETT R
BEAUMIER PL
APPELBAUM JW
FRITZBERG AR
SALK D
Citation: Pl. Weiden et al., RHENIUM-186-LABELED CHIMERIC ANTIBODY NR-LU-13 - PHARMACOKINETICS, BIODISTRIBUTION AND IMMUNOGENICITY RELATIVE TO MURINE ANALOG NR-LU-10, The Journal of nuclear medicine, 34(12), 1993, pp. 2111-2119
Risultati:
1-12
|